儿童癌症治疗相关肝损伤:儿科LI-RADS工作组的影像学综述
本文综述儿童癌症治疗相关肝损伤的多种机制与影像表现,涵盖急性毒性(肝炎、脂肪变性、胆汁淤积、含铁血黄素沉着、血管损伤)和远期效应(肝纤维化、慢性肝衰竭、局灶性肝病变)。定量影像技术可用于弥漫性肝损伤的诊断与监测;治疗相关血管损伤所致的局灶性结节性增生样病变及灌注异常等局灶性病变,需与复发恶性肿瘤或肝转移瘤鉴别。
要点
- 儿童癌症治疗相关肝损伤可表现为脂肪变性、含铁血黄素沉着、纤维化等弥漫性病变,定量影像技术有助于诊断和监测。
- 治疗相关血管损伤可导致局灶性结节性增生样病变和肝脏灌注异常,需与复发恶性肿瘤或肝转移瘤鉴别。
- 免疫抑制所致的肝脏感染也可类似复发肿瘤,影像特征常有助于正确诊断。
核心结论
- 儿童癌症治疗相关肝损伤常见,可发生于治疗期间及治疗结束后数月至数年,影像学评估结合临床和生化筛查对诊断和监测肝并发症至关重要。
研究设计与样本
- 儿科LI-RADS工作组撰写的影像学综述,总结了儿童癌症治疗相关肝损伤的机制、急性和远期表现及影像学评估方法。
关键影像表现/征象
- 急性毒性表现包括肝炎、脂肪变性、脂肪性肝炎、胆汁淤积、含铁血黄素沉着和血管损伤。
- 远期效应包括肝纤维化、慢性肝衰竭和局灶性肝病变的发生。
- 治疗相关血管损伤可导致局灶性结节性增生样病变和肝脏灌注异常,可被误认为复发恶性肿瘤或肝转移瘤。
- 免疫抑制所致的肝脏感染也可与复发恶性肿瘤或肝转移瘤混淆,但常有影像特征有助于正确诊断。
临床应用与阅片要点
- 影像学评估结合临床和生化筛查,用于儿童癌症患者治疗期间及治疗结束后长期监测肝并发症。
- 定量影像技术可用于治疗相关弥漫性肝损伤(如脂肪变性、脂肪性肝炎、铁沉积和纤维化)的诊断和监测。
- 识别局灶性结节性增生样病变和灌注异常的影像特征,有助于与复发恶性肿瘤或肝转移瘤鉴别。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The liver is the primary organ for the metabolism of many chemotherapeutic agents. Treatment-induced liver injury is common in children undergoing cancer therapy. Hepatic injury occurs due to various mechanisms, including biochemical cytotoxicity, hepatic vascular injury, radiation-induced cytotoxicity, and direct hepatic injury through minimally invasive and invasive surgical treatments. Treatment-induced liver injury can be seen contemporaneous with therapy and months to years after therapy is complete. Patients can develop a combination of hepatic injuries manifesting during and after treatment. Acute toxic effects of cancer therapy in children include hepatitis, steatosis, steatohepatitis, cholestasis, hemosiderosis, and vascular injury. Longer-term effects of cancer therapy include hepatic fibrosis, chronic liver failure, and development of focal liver lesions. Quantitative imaging techniques can provide useful metrics for disease diagnosis and monitoring, especially in treatment-related diffuse liver injury such as hepatic steatosis and steatohepatitis, hepatic iron deposition, and hepatic fibrosis. Focal liver lesions, including those developing as a result of treatment-related vascular injury such as focal nodular hyperplasia-like lesions and hepatic perfusion anomalies, as well as hepatic infections occurring as a consequence of immune suppression, can be anxiety provoking and confused with recurrent malignancy or hepatic metastases, although there often are imaging features that help elucidate the correct diagnosis. Radiologic evaluation, in conjunction with clinical and biochemical screening, is integral to diagnosing and monitoring hepatic complications of cancer therapy in pediatric patients during therapy and after therapy completion for long-term surveillance. ©RSNA, 2023 Quiz questions for this article are available in the supplemental material See the invited commentary by Ferraciolli and Gee in this issue.
引用
- Morin CE, Kolbe AB, Alazraki A, et al. Cancer Therapy-related Hepatic Injury in Children: Imaging Review from the Pediatric LI-RADS Working Group. Radiographics. 2023. PMID: 37616168. doi:10.1148/rg.230007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。